{"mainPropery":{"diseaseId":12599,"diseaseName":"Familial partial lipodystrophy due to AKT2 mutations","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12599/familial-partial-lipodystrophy-due-to-akt2-mutations","synonyms":["AKT2-related familial partial lipodystrophy","AKT2-related FPLD"],"synonyms-with-source":[{"name":"AKT2-related familial partial lipodystrophy","source":"OrphaData.Org"},{"name":"AKT2-related FPLD","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"79085"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/familial-partial-lipodystrophy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Familial partial lipodystrophy due to AKT2 mutations. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79085' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:79085' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":11962,"relatedDiseaseName":"Familial partial lipodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4960,"phenoTypeName":"Lipodystrophy","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":10285,"phenoTypeName":"Acanthosis nigricans","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14749,"phenoTypeName":"Decreased adiponectin level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10978,"phenoTypeName":"Decreased serum leptin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3451,"phenoTypeName":"Increased intraabdominal fat","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6035,"phenoTypeName":"Insulin-resistant diabetes mellitus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6068,"phenoTypeName":"Oligomenorrhea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9740,"phenoTypeName":"Polycystic ovaries","frequencyText":"Frequent","percentRanges":"30%-79%"}],"medicalProducts":[],"EncodedName":"Familial_partial_lipodystrophy_due_to_AKT2_mutations"}